These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 7706753)

  • 1. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-gamma secretion in specific allergen-stimulated T cell cultures.
    Jutel M; Pichler WJ; Skrbic D; Urwyler A; Dahinden C; Müller UR
    J Immunol; 1995 Apr; 154(8):4187-94. PubMed ID: 7706753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insect venom immunotherapy induces interleukin-10 production and a Th2-to-Th1 shift, and changes surface marker expression in venom-allergic subjects.
    Bellinghausen I; Metz G; Enk AH; Christmann S; Knop J; Saloga J
    Eur J Immunol; 1997 May; 27(5):1131-9. PubMed ID: 9174602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of the inducible costimulator molecule for the induction of allergic immune responses and its decreased expression on T helper cells after venom immunotherapy.
    Bellinghausen I; Klostermann B; Böttcher I; Knop J; Saloga J
    Immunology; 2004 May; 112(1):80-6. PubMed ID: 15096187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro.
    Akdis CA; Akdis M; Blesken T; Wymann D; Alkan SS; Müller U; Blaser K
    J Clin Invest; 1996 Oct; 98(7):1676-83. PubMed ID: 8833918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultra-rush venom immunotherapy induces differential T cell activation and regulatory patterns according to the severity of allergy.
    Mamessier E; Birnbaum J; Dupuy P; Vervloet D; Magnan A
    Clin Exp Allergy; 2006 Jun; 36(6):704-13. PubMed ID: 16776670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
    Pereira-Santos MC; Baptista AP; Melo A; Alves RR; Soares RS; Pedro E; Pereira-Barbosa M; Victorino RM; Sousa AE
    Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual immunotherapy with Dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production.
    Cosmi L; Santarlasci V; Angeli R; Liotta F; Maggi L; Frosali F; Rossi O; Falagiani P; Riva G; Romagnani S; Annunziato F; Maggi E
    Clin Exp Allergy; 2006 Mar; 36(3):261-72. PubMed ID: 16499636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of immunotherapy to wasp and bee venom.
    Ozdemir C; Kucuksezer UC; Akdis M; Akdis CA
    Clin Exp Allergy; 2011 Sep; 41(9):1226-34. PubMed ID: 21729181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication with antihistamines impairs allergen-specific immunotherapy in mice.
    Johansen P; Senti G; Maria Martínez Gómez J; Kündig TM
    Clin Exp Allergy; 2008 Mar; 38(3):512-9. PubMed ID: 18081882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bee venom immunotherapy induces a shift in cytokine responses from a TH-2 to a TH-1 dominant pattern: comparison of rush and conventional immunotherapy.
    McHugh SM; Deighton J; Stewart AG; Lachmann PJ; Ewan PW
    Clin Exp Allergy; 1995 Sep; 25(9):828-38. PubMed ID: 8564721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased allergen concentration enhances IFN-gamma production by allergic donor T cells expressing a peripheral tissue trafficking phenotype.
    Gardner LM; Spyroglou L; O'Hehir RE; Rolland JM
    Allergy; 2004 Dec; 59(12):1308-17. PubMed ID: 15507100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface membrane antigen alteration on blood basophils in patients with Hymenoptera venom allergy under immunotherapy.
    Siegmund R; Vogelsang H; Machnik A; Herrmann D
    J Allergy Clin Immunol; 2000 Dec; 106(6):1190-5. PubMed ID: 11112905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of allergen-specific antibodies in allergy and specific immunotherapy.
    Blaser K; Akdis CA; Faith A
    Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M; 1999; (93):243-51; discussion 252. PubMed ID: 11487881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom.
    Müller U; Akdis CA; Fricker M; Akdis M; Blesken T; Bettens F; Blaser K
    J Allergy Clin Immunol; 1998 Jun; 101(6 Pt 1):747-54. PubMed ID: 9648701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Humoral immunological response in patients with venom allergy during specific immunotherapy.
    Szymański W; Chyrek-Borowska S
    Rocz Akad Med Bialymst; 1995; 40(2):376-82. PubMed ID: 8834621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils.
    Jutel M; Müller UR; Fricker M; Rihs S; Pichler WJ; Dahinden C
    Clin Exp Allergy; 1996 Oct; 26(10):1112-8. PubMed ID: 8911695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective restimulation of antigen or allergen preactivated T cells using OKT3 F(ab)2 results in the secretion of TH-1 or TH-2-like cytokine patterns.
    Jutel M; Wyss-Coray T; Carballido JM; Blaser K; Müller UR; Pichler WJ
    Clin Exp Allergy; 1995 Nov; 25(11):1108-17. PubMed ID: 8581844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allergen dose dependent cytokine production regulates specific IgE and IgG antibody production.
    Blaser K
    Adv Exp Med Biol; 1996; 409():295-303. PubMed ID: 9095257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. House dust mite immunotherapy results in a decrease in Der p 2-specific IFN-gamma and IL-4 expression by circulating T lymphocytes.
    O'Brien RM; Byron KA; Varigos GA; Thomas WR
    Clin Exp Allergy; 1997 Jan; 27(1):46-51. PubMed ID: 9117880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shift from Th2 to Th1 response in immunotherapy with venoms.
    Kosnik M; Wraber B
    Pflugers Arch; 2000; 440(5 Suppl):R70-1. PubMed ID: 11005617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.